Cargando…
Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemic
BACKGROUND: During the COVID‐19 pandemic focus has been on polyethylene glycol (PEG) and polysorbate as these excipients are constituents in the first vaccines and possible elicitors of allergic reactions to the vaccines. We aimed to evaluate the possibility of vaccinating patients with PEG and/or p...
Autores principales: | Mortz, Charlotte G., Kjaer, Henrik F., Rasmussen, Trine H., Rasmussen, Helene M., Garvey, Lene Heise, Bindslev‐Jensen, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742452/ https://www.ncbi.nlm.nih.gov/pubmed/35028130 http://dx.doi.org/10.1002/clt2.12111 |
Ejemplares similares
-
Fractionated vaccination with mRNA COVID‐19 vaccine is safe for patients with polyethylene glycol allergy
por: Mortz, Charlotte G., et al.
Publicado: (2023) -
Endotyping of IgE-mediated polyethylene glycol and/or polysorbate 80 allergy.
por: Ieven, Toon, et al.
Publicado: (2023) -
Does treatment with antidepressants, antipsychotics, or benzodiazepines hamper allergy skin testing?
por: Kjaer, Henrik Fomsgaard, et al.
Publicado: (2021) -
Patients with suspected allergic reactions to COVID‐19 vaccines can be safely revaccinated after diagnostic work‐up
por: Rasmussen, Trine Holm, et al.
Publicado: (2021) -
Three cases of anaphylaxis following injection of a depot corticosteroid with evidence of IgE sensitization to macrogols rather than the active steroid
por: Brandt, Nicolaj, et al.
Publicado: (2017)